Oral administration of the probiotic combination Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 for human intestinal applications
Gillian E. Gardiner(Waterford Institute of Technology), Gregor Reid(Western University), Miren L. Baroja(Robarts Clinical Trials), Joaquı́n Madrenas(Western University), Andrew W. Bruce(Amgen (Australia)), Christine Heinemann(Lawson Health Research Institute), Dee Beuerman(Lawson Health Research Institute)
Cited by 112
Related Papers
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
|The Journal of Urology|1976|1.8k
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
|The Journal of Urology|2016|1.5k
Oral use of<i>Lactobacillus rhamnosus</i>GR-1 and<i>L. fermentum</i>RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women
|FEMS Immunology & Medical Microbiology|2003|508
Oral probiotics can resolve urogenital infections
|FEMS Immunology & Medical Microbiology|2001|451
Probiotic<i>Lactobacillus</i>dose required to restore and maintain a normal vaginal flora
|FEMS Immunology & Medical Microbiology|2001|306